A consortium of private credit lenders, led by Ares Capital, has increased its loan to a health-care software company currently undergoing an acquisition by Veritas Capital. The additional funding underscores the lenders’ confidence in the company’s prospects amid the transaction. Details of the revised loan amount were not disclosed, but the move signals a significant commitment by the private credit group to support the deal.
The financing arrangement features a strong contractual clause that maintains the company’s existing debt structure unchanged even as ownership shifts. This provision ensures that the company’s current financial obligations remain intact, providing stability for all parties involved during the transitional period. Such clauses are common in leveraged buyouts and acquisitions, offering lenders protection by preserving priority claims on the company’s assets.
Veritas Capital’s acquisition aims to leverage the health-care software platform’s capabilities to expand its portfolio within the sector. The deal aligns with Veritas’s ongoing strategy to invest in technology-driven health-care solutions, though specific terms of the acquisition have not been publicly disclosed. The completion of the transaction is expected to reinforce the company’s position in the evolving health-care market.
The transaction highlights the active role of private credit lenders in funding strategic corporate deals, especially in the health-care sector, which continues to attract significant investment. As companies navigate complex mergers and acquisitions, financing arrangements like this play a critical role in enabling strategic growth while safeguarding lender interests.